Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark

作者: Thomas Stig Hermansen , Vibeke Østergaard Thomsen , Troels Lillebaek , Pernille Ravn

DOI: 10.1371/JOURNAL.PONE.0093986

关键词:

摘要: Background The QuantiFERON-TB-Gold Test (QFT) is more specific than the Mantoux skin-test to discriminate between Mycobacterium tuberculosis (MTB) and non-tuberculous mycobacterial (NTM) infections. Here we study performance of QFT in patients with NTM disease. Methods From 2005 2011, nationwide patient data on positive cultures (n = 925) were combined results 16,133), both retrieved from International Reference Laboratory Mycobacteriology, Denmark. A total 112 infections had a performed, 53 definite disease, 10 possible disease 49 colonization. Results QFT was 8% (4/53) 40% (4/10) 31% (15/49) colonization. Positivity rate lowest among infected without RD1 region 4% (2/50). None 15 children MAC lymphadenitis QFT. Conclusion This one largest assessing IGRAs TB low-incidence setting. Our showed that holds potential MTB We found no IGRA test not sharing RD1-region resulting 100% specificity suggest child presenting cervical may be helpful distinguishing lymphadenitis.

参考文章(42)
Y Obase, N Okimoto, Y Kobashi, K Mouri, S Yagi, M Oka, T Matsushima, T Kageoka, N Miyashita, Clinical evaluation of the QuantiFERON-TB Gold test in patients with non-tuberculous mycobacterial disease. International Journal of Tuberculosis and Lung Disease. ,vol. 13, pp. 1422- 1426 ,(2009)
P Vernazza, I Binet, M Hoffmann, D Tsinalis, W Fierz, Assessment of an Interferon-gamma release assay for the diagnosis of latent tuberculosis infection in haemodialysis patient. Swiss Medical Weekly. ,vol. 140, pp. 286- 292 ,(2010) , 10.4414/SMW.2010.12960
Elwood Rk, Hernández-Garduño E, Rodrigues M, The incidence of pulmonary non-tuberculous mycobacteria in British Columbia, Canada. International Journal of Tuberculosis and Lung Disease. ,vol. 13, pp. 1086- 1093 ,(2009)
D. Vincenti, S. Carrara, O. Butera, F. Bizzoni, R. Casetti, E. Girardi, D. Goletti, Response to region of difference 1 (RD1) epitopes in human immunodeficiency virus (HIV)-infected individuals enrolled with suspected active tuberculosis: a pilot study Clinical and Experimental Immunology. ,vol. 150, pp. 91- 98 ,(2007) , 10.1111/J.1365-2249.2007.03462.X
Timothy Blackmore, Arthur Morris, Leo McKnight, Sean Munroe, Joshua Freeman, David Hammer, Incidence of nontuberculous mycobacterial disease in New Zealand, 2004. The New Zealand Medical Journal. ,vol. 120, ,(2007)
Kevin L. Winthrop, Erin McNelley, Brian Kendall, Allison Marshall-Olson, Christy Morris, Maureen Cassidy, Ashlen Saulson, Katrina Hedberg, Pulmonary Nontuberculous Mycobacterial Disease Prevalence and Clinical Features An Emerging Public Health Disease American Journal of Respiratory and Critical Care Medicine. ,vol. 182, pp. 977- 982 ,(2010) , 10.1164/RCCM.201003-0503OC
Seok Hoon Jeong, Young Ae Kang, Sang Kook Lee, Eun Ja Lee, Se Kyu Kim, Joon Chang, Changing epidemiology of nontuberculous mycobacterial lung disease in South Korea Scandinavian Journal of Infectious Diseases. ,vol. 44, pp. 733- 738 ,(2012) , 10.3109/00365548.2012.681695
Shahla Riazi, Barbara Zeligs, Henry Yeager, Stephen M. Peters, German A. Benavides, Onorina Di Mita, Joseph A. Bellanti, Rapid diagnosis of Mycobacterium tuberculosis infection in children using interferon-gamma release assays (IGRAs). Allergy and Asthma Proceedings. ,vol. 33, pp. 217- 226 ,(2012) , 10.2500/AAP.2012.33.3574
Rachel M. Thomson, , , Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerging Infectious Diseases. ,vol. 16, pp. 1576- 1583 ,(2010) , 10.3201/EID1610.091201